Sparsha Pharma International Collaborations
Working in a collaborative mode has many advantages because it promotes problem-solving, enables workers to learn from one another, increases workforce productivity, makes general problem-solving easier, increases the organization's potential for change, and makes remote teams more effective. Pharmaceutical industry partnerships include a variety of goals, including medication research, clinical trials, and imaging.
Companies will keep working together and sharing knowledge to create treatments that target a variety of diseases. Pharmaceutical industry collaborations focus on diverse areas, including clinical trials, imaging, and drug discovery and development.
The Japanese company has a research collaboration and licence arrangement with Sparsha Pharma International Pvt. Ltd. and Sparsha Pharma, USA. The collaboration was established in order to create small molecule inhibitors for a variety of therapeutic targets.
Technology Partner
Sparsha Pharma has technical collaboration with leading Japanese company, M/s. Teikoku Seiyaku Co. Ltd., a group of companies established more than 160 years ago in Japan, dealing in TDDS and allied products. M/s Sparsha Pharma USA, Inc. has recently been incorporated as one of the technology partners of the company with view to exchanging information for the prosperity of both.
With the above support in-place, Sparsha Pharma has emerged as the pioneer in TDDS in India with three products already in the market under pain management and the pipeline includes transdermal patches in Pain Management, CNS and respiratory.